Results 221 to 230 of about 76,034 (338)

Development of an Artificial Intelligence Verification System Model for Clinical Biochemistry Laboratories Using Machine Learning

iLABMED, EarlyView.
The constructed AI verification system performed excellently in terms of accuracy and efficiency. This study provides a new solution for the intelligent verification of clinical biochemistry laboratories and has certain application value. ABSTRACT Background With the exponential growth of testing samples in clinical biochemistry laboratories ...
Lin Zhu, Jie Feng, Rong Zheng, Jianzhu Wang, Jin Dong, Jing Gao, Qiuliang Yang, Xuemei Wei, Hui Ding, Xu Zhang, Jinyao Ma, Jingzhao Mei, Yanhong Gao   +12 more
wiley   +1 more source

Radiolabeling lipoproteins to study and manage disease. [PDF]

Eur J Nucl Med Mol Imaging
Pérez-Medina C, Fisher EA, Fayad ZA, Mulder WJM, Teunissen AJP.   +4 more
europepmc   +1 more source

Major lipids, apolipoproteins, and risk of vascular disease [PDF]

, 2009
, Danesh, John, Evans, Alun, Yarnell, John   +3 more
core   +1 more source

Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men

, 1982
Moti L. Kashyap, Roger L. Barnhart, Laxmi Srivastava, Gladys Perisutti, Peter Vink, C. Allen, Elizabeth Hogg, D Brady, Charles J. Glueck, Richard L. Jackson   +9 more
openalex   +1 more source

Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. [PDF]

, 1984
Ian Rowe, A.K. Soutar, I. Trayner, M L Baltz, Frederick C. de Beer, Lucy S. K. Walker, David E. Bowyer, J. Herbert, A. Feinstein, Mark B. Pepys   +9 more
openalex   +1 more source

Apolipoprotein A-II [PDF]

, 2018
D. Peetz, K. J. Lackner
openaire   +2 more sources

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

iMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu, Yu An, Yage Du, Zhaoming Cao, Jie Zheng, Jingya Wang, Tingyi Li, Xingen Lei, Yanhui Lu   +8 more
wiley   +1 more source

HDL proteome and apolipoproteins concentrations in severe ICU COVID-19 patients. [PDF]

Lipids Health Dis
Begue F, Veeren B, Rondeau P, Florence AM, Jamard S, Montravers P, Tanaka S, Meilhac O, French COVID Study Group.   +8 more
europepmc   +1 more source

Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses.

, 1985
Bunyen Teng, Allan D. Sniderman, Ronald M. Krauss, Peter O. Kwiterovich, R W Milne, Yves L. Marcel   +5 more
openalex   +1 more source

High-mannose structure of apolipoprotein-B from low-density lipoproteins of human plasma [PDF]

, 1985
Matti Vauhkonen, Juha Viitala, Jaakko Parkkinen, Heikki Rauvala   +3 more
openalex   +1 more source